Updates from the 48th Annual San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer
Tue Jan 06 2026
- Clinical Applications of Circulating Tumor DNA - Predicting Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer - Novel Therapeutics and Therapy Related Toxicity in Triple Negative Breast Cancer - Questions for Our Panel of Experts